vs
Side-by-side financial comparison of ADAMAS TRUST, INC. (ADAM) and LIFECORE BIOMEDICAL, INC. \DE\ (LFCR). Click either name above to swap in a different company.
ADAMAS TRUST, INC. is the larger business by last-quarter revenue ($43.2M vs $31.1M, roughly 1.4× LIFECORE BIOMEDICAL, INC. \DE\). ADAMAS TRUST, INC. runs the higher net margin — 124.0% vs -32.1%, a 156.1% gap on every dollar of revenue. On growth, ADAMAS TRUST, INC. posted the faster year-over-year revenue change (61.6% vs -4.5%). ADAMAS TRUST, INC. produced more free cash flow last quarter ($125.9M vs $25.0K). Over the past eight quarters, ADAMAS TRUST, INC.'s revenue compounded faster (55.5% CAGR vs -0.1%).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
ADAM vs LFCR — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $43.2M | $31.1M |
| Net Profit | $53.5M | $-10.0M |
| Gross Margin | — | 25.0% |
| Operating Margin | — | -9.9% |
| Net Margin | 124.0% | -32.1% |
| Revenue YoY | 61.6% | -4.5% |
| Net Profit YoY | 270.5% | -52.0% |
| EPS (diluted) | $0.45 | $-0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $43.2M | — | ||
| Q3 25 | $36.6M | $31.1M | ||
| Q2 25 | $36.4M | — | ||
| Q1 25 | $33.1M | $35.2M | ||
| Q4 24 | $26.7M | $32.6M | ||
| Q3 24 | $20.2M | $24.7M | ||
| Q2 24 | $19.0M | — | ||
| Q1 24 | $17.9M | $35.7M |
| Q4 25 | $53.5M | — | ||
| Q3 25 | $44.8M | $-10.0M | ||
| Q2 25 | $8.5M | — | ||
| Q1 25 | $42.2M | $-14.8M | ||
| Q4 24 | $-31.4M | $-6.6M | ||
| Q3 24 | $42.8M | $-16.2M | ||
| Q2 24 | $-15.6M | — | ||
| Q1 24 | $-57.9M | $15.6M |
| Q4 25 | — | — | ||
| Q3 25 | — | 25.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 28.0% | ||
| Q4 24 | — | 34.0% | ||
| Q3 24 | — | 21.8% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 33.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | -9.9% | ||
| Q2 25 | 11.7% | — | ||
| Q1 25 | — | -25.7% | ||
| Q4 24 | -119.0% | -6.0% | ||
| Q3 24 | — | -46.9% | ||
| Q2 24 | -124.7% | — | ||
| Q1 24 | -448.8% | -2.5% |
| Q4 25 | 124.0% | — | ||
| Q3 25 | 122.5% | -32.1% | ||
| Q2 25 | 23.4% | — | ||
| Q1 25 | 127.4% | -42.0% | ||
| Q4 24 | -117.5% | -20.2% | ||
| Q3 24 | 211.7% | -65.7% | ||
| Q2 24 | -81.9% | — | ||
| Q1 24 | -324.1% | 43.8% |
| Q4 25 | $0.45 | — | ||
| Q3 25 | $0.36 | $-0.29 | ||
| Q2 25 | $-0.04 | — | ||
| Q1 25 | $0.33 | $-0.47 | ||
| Q4 24 | $-0.46 | $-0.25 | ||
| Q3 24 | $0.36 | $-0.53 | ||
| Q2 24 | $-0.29 | — | ||
| Q1 24 | $-0.75 | $0.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $210.3M | $18.9M |
| Total DebtLower is stronger | $735.8M | $136.0M |
| Stockholders' EquityBook value | $1.4B | $-10.5M |
| Total Assets | $12.6B | $235.2M |
| Debt / EquityLower = less leverage | 0.52× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $210.3M | — | ||
| Q3 25 | $185.3M | $18.9M | ||
| Q2 25 | $160.4M | — | ||
| Q1 25 | $177.1M | $5.4M | ||
| Q4 24 | $167.4M | $9.5M | ||
| Q3 24 | $195.1M | — | ||
| Q2 24 | $235.5M | — | ||
| Q1 24 | $226.9M | — |
| Q4 25 | $735.8M | — | ||
| Q3 25 | $766.6M | $136.0M | ||
| Q2 25 | $653.0M | — | ||
| Q1 25 | $654.4M | $124.9M | ||
| Q4 24 | $573.2M | $111.3M | ||
| Q3 24 | $699.4M | $106.3M | ||
| Q2 24 | $800.7M | — | ||
| Q1 24 | $1.0B | $97.1M |
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.4B | $-10.5M | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $1.4B | $2.2M | ||
| Q4 24 | $1.4B | $15.4M | ||
| Q3 24 | $1.4B | $-3.9M | ||
| Q2 24 | $1.4B | — | ||
| Q1 24 | $1.5B | $17.7M |
| Q4 25 | $12.6B | — | ||
| Q3 25 | $12.4B | $235.2M | ||
| Q2 25 | $10.6B | — | ||
| Q1 25 | $10.0B | $237.7M | ||
| Q4 24 | $9.2B | $255.4M | ||
| Q3 24 | $8.9B | $246.8M | ||
| Q2 24 | $8.2B | — | ||
| Q1 24 | $7.4B | $246.2M |
| Q4 25 | 0.52× | — | ||
| Q3 25 | 0.55× | — | ||
| Q2 25 | 0.47× | — | ||
| Q1 25 | 0.47× | 56.05× | ||
| Q4 24 | 0.41× | 7.20× | ||
| Q3 24 | 0.48× | — | ||
| Q2 24 | 0.56× | — | ||
| Q1 24 | 0.67× | 5.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $134.0M | $1.8M |
| Free Cash FlowOCF − Capex | $125.9M | $25.0K |
| FCF MarginFCF / Revenue | 291.6% | 0.1% |
| Capex IntensityCapex / Revenue | 18.9% | 5.6% |
| Cash ConversionOCF / Net Profit | 2.50× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-16.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $134.0M | — | ||
| Q3 25 | $6.9M | $1.8M | ||
| Q2 25 | $39.2M | — | ||
| Q1 25 | $25.8M | $1.2M | ||
| Q4 24 | $14.1M | $-6.1M | ||
| Q3 24 | $-922.0K | $-613.0K | ||
| Q2 24 | $-993.0K | — | ||
| Q1 24 | $-13.1M | $-1.4M |
| Q4 25 | $125.9M | — | ||
| Q3 25 | — | $25.0K | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-4.3M | ||
| Q4 24 | $-10.6M | $-8.6M | ||
| Q3 24 | $-8.6M | $-4.0M | ||
| Q2 24 | $-8.6M | — | ||
| Q1 24 | $-19.1M | $-7.8M |
| Q4 25 | 291.6% | — | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -12.1% | ||
| Q4 24 | -39.6% | -26.3% | ||
| Q3 24 | -42.3% | -16.3% | ||
| Q2 24 | -44.9% | — | ||
| Q1 24 | -107.0% | -21.8% |
| Q4 25 | 18.9% | — | ||
| Q3 25 | — | 5.6% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 15.5% | ||
| Q4 24 | 92.3% | 7.5% | ||
| Q3 24 | 37.7% | 13.9% | ||
| Q2 24 | 39.7% | — | ||
| Q1 24 | 33.5% | 17.8% |
| Q4 25 | 2.50× | — | ||
| Q3 25 | 0.15× | — | ||
| Q2 25 | 4.59× | — | ||
| Q1 25 | 0.61× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.02× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -0.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ADAM
| Other | $19.6M | 45% |
| Constructive Loans LLC | $14.4M | 33% |
| Multifamily | $9.1M | 21% |
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
